Abstract
Bone tissue engineering is a therapeutic approach based on the combination of scaffolds, growth factors, and cells. Regarding the cells, adipose tissue-derived mesenchymal stem cells (AT-MSC) can be easily harvested at lesser morbidity. However, its use is limited due to its lower less osteogenic potential. In this context, strategies to increase the therapeutic potential of MSCs or "Cell…